Skip to main content
. 2022 Mar 24;9:807810. doi: 10.3389/fnut.2022.807810

Table 3.

Nuclear magnetic resonance spectral analysis of GlycA and lipoprotein particles and size of the nine participants.

Baseline 12 weeks Changes (12 weeks - baseline)
Median P25 P75 Median P25 P75 Median P25 P75 p -value
GlycA, μmol/L 378.0 340.0 420.0 348.0 317.0 374.0 −23.0 −64.0 −17.0 0.01
VLDL and chylomicron
Total, nmol/L 84.1 81.6 93.1 70.9 49.9 76.4 −23.6 −34.6 0.2 0.05
Large, nmol/L 4.0 3.3 8.0 3.0 2.4 5.1 −0.4 −3.3 0.1 0.20
Medium, nmol/L 33.5 21.2 47.1 21.8 15.1 28.1 −4.6 −19.6 −1.8 0.10
Small, nmol/L 44.2 35.6 53.0 35.9 30.8 38.1 −15.8 −25.0 5.2 0.25
IDL particles, nmol/L 35.0 29.0 123.0 72.0 60.0 142.0 25.0 10.0 57.0 0.20
LDL particles
Total, nmol/L 1000.0 835.0 1337.0 822.0 799.0 1150.0 −75.0 −187.0 −34.0 0.02
Large, nmol/L 322.0 163.0 508.0 100.0 17.0 239.0 −153.0 −222.0 −131.0 0.01
Small, nmol/L 765.0 509.0 849.0 709.0 641.0 812.0 14.0 −87.0 47.0 0.89
HDL particles
Total, μmol/L 33.7 30.6 35.3 34.0 30.8 34.8 0.5 −0.5 2.3 0.74
Large, μmol/L 7.5 5.0 8.7 6.9 5.9 7.8 0.3 −1.3 1.0 0.98
Medium, μmol/L 6.3 4.0 8.1 6.4 5.6 8.0 1.1 −0.2 4.4 0.38
Small, μmol/L 22.1 15.8 23.5 19.4 14.2 22.5 −1.1 −4.3 1.6 0.50
Size
VLDL, nm 47.5 45.7 50.8 47.6 44.9 48.7 −0.8 −4.5 3.1 0.57
LDL, nm 20.2 20.2 20.7 20.0 19.8 20.2 −0.3 −0.4 −0.2 0.94
HDL, nm 9.3 8.8 9.9 9.3 9.3 9.5 0.0 −0.3 0.2 0.02
Triglyceride, mg/dL* 159.0 129.0 188.0 120.0 77.0 168.0 −20.0 −86.0 −3.0 0.10
VDLD and chylomicron TG, mg/dL* 112.0 98.0 133.0 93.0 70.0 115.0 −18.0 −60.0 −2.0 0.09
HDL cholesterol, mg/dL* 49.0 47.0 52.0 47.0 45.0 51.0 −2.0 −4.0 3.0 0.41
Lipoprotein insulin resistance score 48.0 41.0 56.0 40.0 38.0 55.0 −4.0 −5.0 −1.0 0.18

SD, standard deviation; P25, 25th percentile; P75, 75th percentile; VLDL, very low density lipoprotein; IDL, intermediate density lipoprotein; LDL, low density lipoprotein; HDL, high density lipoprotein; TG, triglyceride.

*

Calculated values provided by LabCorp (Morrisville, NC, USA).